Literature DB >> 2845586

Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging--preliminary clinical experience in five patients.

H Pettersson1, J Eliasson, N Egund, B Rööser, H Willén, A Rydholm, N O Berg, S Holtås.   

Abstract

In a preliminary report of a clinical trial of gadolinium-DTPA (Gd-DTPA) for enhancement of soft tissue tumors in magnetic resonance imaging (MRI), experience of the first five cases is presented. Enhancement was found to give better delineation of the tumor in richly vascularized parts of the tumors, compressed tissue immediately surrounding the tumor, and in atrophic, but richly vascularized, muscle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845586     DOI: 10.1007/bf00367175

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  6 in total

1.  Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

Authors:  D H Carr; J Brown; G M Bydder; R E Steiner; H J Weinmann; U Speck; A S Hall; I R Young
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

2.  Theoretical considerations for optimizing intensity differences between primary musculoskeletal tumors and normal tissue with spin-echo magnetic resonance imaging.

Authors:  M L Richardson; E G Amparo; T Gillespy; C A Helms; B E Demas; H K Genant
Journal:  Invest Radiol       Date:  1985-08       Impact factor: 6.016

3.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

Authors:  H J Weinmann; R C Brasch; W R Press; G E Wesbey
Journal:  AJR Am J Roentgenol       Date:  1984-03       Impact factor: 3.959

4.  Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.

Authors:  R C Brasch; H J Weinmann; G E Wesbey
Journal:  AJR Am J Roentgenol       Date:  1984-03       Impact factor: 3.959

5.  Primary musculoskeletal tumors: examination with MR imaging compared with conventional modalities.

Authors:  H Pettersson; T Gillespy; D J Hamlin; W F Enneking; D S Springfield; E R Andrew; S Spanier; R Slone
Journal:  Radiology       Date:  1987-07       Impact factor: 11.105

6.  Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.

Authors:  H Pettersson; N Ackerman; J Kaude; R E Googe; A A Mancuso; K N Scott; R H Hackett; D A Hager; S Caballero
Journal:  Acta Radiol       Date:  1987 Jan-Feb       Impact factor: 1.990

  6 in total
  5 in total

Review 1.  Cystic lesion around the hip joint.

Authors:  Kiminori Yukata; Sho Nakai; Tomohiro Goto; Yuichi Ikeda; Yasunori Shimaoka; Issei Yamanaka; Koichi Sairyo; Jun-Ichi Hamawaki
Journal:  World J Orthop       Date:  2015-10-18

2.  The use of intravenous gadopentetate dimeglumine in magnetic resonance imaging of synovial lesions.

Authors:  C G Whitten; T E Moore; W T Yuh; M H Kathol; D L Renfrew; C W Walker
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

3.  Magnetic resonance imaging of musculoaponeurotic fibromatosis.

Authors:  J M Hawnaur; J P Jenkins; I Isherwood
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

4.  Iliopsoas bursa of the rheumatoid hip joint. A case report and review of the literature.

Authors:  M Kataoka; T Torisu; M Nakamura; K Uchida
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

5.  Osteoid osteoma and osteoblastoma: MRI appearances and the significance of ring enhancement.

Authors:  B A Youssef; M C Haddad; A Zahrani; H S Sharif; J L Morgan; M al-Shahed; A al-Sabty; R Choudary
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.